NYSE - Delayed Quote USD

Koninklijke Philips N.V. (PHG)

21.01 +0.40 (+1.94%)
At close: April 23 at 4:00 PM EDT
20.97 -0.04 (-0.19%)
Pre-Market: 9:21 AM EDT
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
18,169,000.00
18,169,000.00
17,827,000.00
17,156,000.00
17,312,000.00
Cost of Revenue
10,721,000.00
10,721,000.00
10,633,000.00
9,988,000.00
9,493,000.00
Gross Profit
7,448,000.00
7,448,000.00
7,194,000.00
7,168,000.00
7,820,000.00
Operating Expense
7,616,000.00
7,616,000.00
7,371,000.00
6,545,000.00
6,416,000.00
Operating Income
-168,000.00
-168,000.00
-177,000.00
623,000.00
1,404,000.00
Net Non Operating Interest Income Expense
-266,000.00
-266,000.00
-223,000.00
-137,000.00
-180,000.00
Other Income Expense
-92,000.00
-92,000.00
-1,332,000.00
22,000.00
-13,000.00
Pretax Income
-526,000.00
-526,000.00
-1,731,000.00
509,000.00
1,211,000.00
Tax Provision
-73,000.00
-73,000.00
-113,000.00
-103,000.00
212,000.00
Net Income Common Stockholders
-466,000.00
-466,000.00
-1,608,000.00
3,319,000.00
1,187,000.00
Diluted NI Available to Com Stockholders
-466,000.00
-466,000.00
-1,608,000.00
3,319,000.00
1,187,000.00
Basic EPS
-0.58
-0.49
-1.68
3.37
1.25
Diluted EPS
-0.58
-0.49
-1.68
3.35
1.23
Basic Average Shares
963,093.36
958,452.26
962,119.91
985,788.50
948,261.27
Diluted Average Shares
963,093.36
958,452.26
962,119.91
991,412.22
957,562.94
Total Operating Income as Reported
-115,000.00
-115,000.00
-1,529,000.00
553,000.00
1,264,000.00
Total Expenses
18,337,000.00
18,337,000.00
18,004,000.00
16,533,000.00
15,909,000.00
Net Income from Continuing & Discontinued Operation
-466,000.00
-466,000.00
-1,608,000.00
3,319,000.00
1,187,000.00
Normalized Income
-460,980.00
-460,980.00
-377,450.00
588,500.00
994,296.00
Interest Income
46,000.00
46,000.00
25,000.00
18,000.00
13,000.00
Interest Expense
306,000.00
306,000.00
244,000.00
164,000.00
182,000.00
Net Interest Income
-266,000.00
-266,000.00
-223,000.00
-137,000.00
-180,000.00
EBIT
-220,000.00
-220,000.00
-1,487,000.00
673,000.00
1,393,000.00
EBITDA
1,041,000.00
1,041,000.00
115,000.00
1,996,000.00
2,855,000.00
Reconciled Cost of Revenue
10,721,000.00
10,721,000.00
10,633,000.00
9,988,000.00
9,493,000.00
Reconciled Depreciation
1,261,000.00
1,261,000.00
1,602,000.00
1,323,000.00
1,462,000.00
Net Income from Continuing Operation Net Minority Interest
-456,000.00
-456,000.00
-1,621,000.00
608,000.00
991,000.00
Total Unusual Items Excluding Goodwill
6,000.00
6,000.00
-1,330,000.00
26,000.00
-4,000.00
Total Unusual Items
6,000.00
6,000.00
-1,330,000.00
26,000.00
-4,000.00
Normalized EBITDA
1,035,000.00
1,035,000.00
1,445,000.00
1,970,000.00
2,859,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,020.00
1,020.00
-86,450.00
6,500.00
-704.00
12/31/2020 - 3/17/1980

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SNN Smith & Nephew plc
24.80
+1.81%
 
PODD Insulet Corporation
167.27
+1.73%
 
MASI Masimo Corporation
136.95
+1.96%
 
BSX Boston Scientific Corporation
68.99
+1.43%
 
CNMD CONMED Corporation
71.31
-1.79%
 
BIO Bio-Rad Laboratories, Inc.
285.28
+1.84%
 
QDEL QuidelOrtho Corporation
40.40
+3.38%
 
MDT Medtronic plc
81.29
+0.89%
 
AXNX Axonics, Inc.
66.47
-0.55%
 
INSP Inspire Medical Systems, Inc.
233.93
+3.87%